Table 2.
Distribution of urine protein-to-creatinine ratio measurements overall and relative to AKI episodes
| Total, n=2048 | ||
|---|---|---|
| AKI during Follow-Up, n=324 | Non-AKI during Follow-Up, n=1724 | |
| No. of urine protein-to-creatinine ratio measurements overall | ||
| Mean (±SD) no. of urine protein-to-creatinine ratio measurements | 6 (±3) | 5 (±3) |
| Median [interquartile range] number of urine protein-to-creatinine ratio measurements | 5 [4–7] | 5 [3–7] |
| Urine protein-to-creatinine ratio measurements relative to AKI episode | ||
| Number of urine protein-to-creatinine ratio measurements pre-AKI | ||
| Mean (±SD) | 3 (±2) | |
| Median [interquartile range] | 2 [1–3] | |
| Time between last pre-AKI urine protein-to-creatinine ratio and AKI episode | ||
| Mean (±SD) days | 199 (±131) | |
| Median [interquartile range] days | 190 [100–283] | |
| No. of urine protein-to-creatinine ratio measurements post-AKI | ||
| Mean (±SD) | 3 (±2) | |
| Median [interquartile range] | 2 [1–3] | |
| Time between AKI episode and first post-AKI urine protein-to-creatinine ratio | ||
| Mean (±SD) days | 194 (±138) | |
| Median [interquartile range] days | 170 [96–265] | |